Table:
begin	end	state
1	32	non-cytoplasmic
33	53	transmembrane
54	59	cytoplasmic
60	82	transmembrane
83	99	non-cytoplasmic
100	121	transmembrane
122	129	cytoplasmic
130	152	transmembrane
153	173	non-cytoplasmic
174	199	transmembrane
200	210	cytoplasmic
211	232	transmembrane
233	276	non-cytoplasmic
277	300	transmembrane
301	319	cytoplasmic
320	340	transmembrane
341	346	non-cytoplasmic
347	368	transmembrane
369	369	cytoplasmic
370	388	transmembrane
389	407	non-cytoplasmic
408	438	transmembrane
439	559	cytoplasmic

Input:
>BWI76_RS17465
MNRLFSSHVMPFRALIDACWKEKYTASRFTRDVIAGITVGIIAIPLAMALAIGSGVAPQY
GLYTSAVAGIVIALTGGSRFSVSGPTAAFVVILYPVSQQFGLAGLLVATLMSGIFLILFG
LARFGRLIEYIPLSVTLGFTSGIGITIGTMQIKDFLGLQMAHVPEHYLQKVGALAMALPT
INPGDAAIGVVTLGTLIIWPRLGIRLPGHLPALLAGCAVMGVVNLLGGHVATIGSQFHYI
LADGSQGNGIPQLLPQLVLPWDMPGSDFTLSWSSLQALLPAAFSMAMLGAIESLLCAVVL
DGMTGTKHKANSELIGQGLGNIVAPFFGGITATAAIARSAANVRAGATSPVSAVIHALLV
IMALLVLAPLLSWLPLSAMAALLLMVAWNMSEAHKVVNLLRYAPKDDIIVMLMCMSLTVL
FDMVIAISVGIVLASLLFMRRIARMTRLAPVNVEVPDDVLVLRVIGPLFFAAAEGLFTDL
ETRVAGKRIVVLKWDAVPVLDAGGLDAFQRFVKKLPEGCELRVSNLEFQPLRTLARAGVK
PIPGRLSFYPDRNAALADI

Or try the official Phobius web server, which has a different display

Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server